Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03624985 · ClinicalTrials.gov registry record · Phase 4
The Effect of Perioperative Intravenous Lidocaine Infusion on Opioid Consumption After Lumbar Spine Surgery
A Phase 4 study, sponsored by University of Vermont Medical Center.
- Terminated
- Registry status
- Phase 4
- Development phase
- 61
- Enrollment target
NCT03624985 is a Phase 4 study that was terminated before completion, run by University of Vermont Medical Center. The registered enrollment target is 61 participants.
The verdict
NCT03624985, a Phase 4 study, was terminated before completion, sponsored by University of Vermont Medical Center.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 61 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether an infusion of lidocaine during surgery can reduce the need for postoperative opioid pain medication use in patients undergoing lumbar spine surgery. Participants will be recruited by spine surgeons from their pool of patients who are presenting for surgery at University of Vermont Medical Center. If they agree to participate, patients will be assigned at random to receive either an infusion of lidocaine during surgery, or an infusion of saline with 5% dextrose. Subjects will also be asked to complete a 15-item questionnaire that asks about health, quality of life, and level of pain, at three timepoints. Patients will also be asked to rate their level of pain at multiple timepoints after surgery, and we will collect the additionally data from patients' medical records.
Interventions
- DRUG Placebo Infusion
- DRUG Intravenous Lidocaine Infusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2018-06-04 |
| Est. Completion | 2019-10-14 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03624985
The ClinicalTrials.gov registry entry for NCT03624985 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Vermont Medical Center, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Infusion is the first listed.
NCT03624985 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03624985 about?
NCT03624985 is a clinical study titled "The Effect of Perioperative Intravenous Lidocaine Infusion on Opioid Consumption After Lumbar Spine Surgery". The purpose of this study is to determine whether an infusion of lidocaine during surgery can reduce the need for postoperative opioid pain medication use in patients undergoing lumbar spine surgery. Participants will be recruited by spine surgeons from their pool of patients who are presenting for...
What is the current status of trial NCT03624985?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 61 participants. The study started on 2018-06-04. Estimated completion is 2019-10-14.
What interventions are being tested in trial NCT03624985?
The interventions under investigation include: Placebo Infusion (DRUG), Intravenous Lidocaine Infusion (DRUG).
Who is sponsoring clinical trial NCT03624985?
This trial is sponsored by University of Vermont Medical Center, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.